Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Atherosclerosis. Supplements|December 11, 2019
Lipoprotein(a) - Marker for cardiovascular risk and target for lipoprotein apheresisReinhard Klingel, Franz Heigl, Volker Schettler, et al.Journal of Exposure Science & Environmental Epidemiology|July 21, 2016
Use of plasma exchange or double filtration plasmapheresis to reduce body burden of polychlorinated biphenyls: A pilot trialMonika Gube, Thomas Schettgen, Thomas Kraus, et al.Journal of Clinical Apheresis|March 13, 2020
Homozygous familial hypercholesterolemia with severe involvement of the aortic valve-A sibling-controlled case study on the efficacy of lipoprotein apheresisMatthias Galiano, Johanna Hammersen, Katja Sauerstein, et al.Circulation|September 24, 2013
Lipoprotein apheresis in patients with maximally tolerated lipid-lowering therapy, lipoprotein(a)-hyperlipoproteinemia, and progressive cardiovascular disease: prospective observational multicenter studyJosef Leebmann, Eberhard Roeseler, Ulrich Julius, et al.Atherosclerosis|October 22, 2025
Lipoprotein apheresis for lipoprotein(a)-associated progressive atherosclerotic cardiovascular disease: 12-years follow-upReinhard Klingel, Ulrich Julius, Wanja M Bernhardt, et al.Pediatric Nephrology (Berlin, Germany)|March 5, 2018
Multimodal lipid-lowering treatment in pediatric patients with homozygous familial hypercholesterolemia-target attainment requires further increase of intensityGünter Klaus, Christina Taylan, Rainer Büscher, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|July 16, 2016
Lipoprotein Apheresis for Lipoprotein(a)-Associated Cardiovascular Disease: Prospective 5 Years of Follow-Up and Apolipoprotein(a) CharacterizationEberhard Roeseler, Ulrich Julius, Franz Heigl, et al.Journal of Clinical Apheresis|March 1, 2019
Real-world study: Escalating targeted lipid-lowering treatment with PCSK9-inhibitors and lipoprotein apheresisRalf Spitthöver, Tilmann Röseler, Ulrich Julius, et al.The American Journal of Cardiology|September 18, 2020
Cardiovascular Outcome of Pediatric Patients With Bi-Allelic (Homozygous) Familial Hypercholesterolemia Before and After Initiation of Multimodal Lipid Lowering Therapy Including Lipoprotein ApheresisChristina Taylan, Joenna Driemeyer, Claus P Schmitt, et al.Pageof 2